Rapidscan Pharma Solutions Inc. has been acquired by GE Healthcare
December 2016 — The shareholders of Rapidscan Pharma Solutions, Inc. (Rapidscan) have sold the company to GE Healthcare, a global provider of contrast media, medical technologies and services, and biomanufacturing solutions. Financial details have not been disclosed.
Rapidscan is a privately held healthcare company specializing in the production of Rapiscan®, a selective coronary vasodilator for radionuclide myocardial perfusion imaging. The company was founded in 2010 by leading members of the team that discovered and developed regadenoson, a new pharmacological stress agent used in the diagnosis and risk stratification of cardiovascular disease.
Headquartered in Chicago, GE Healthcare is a unit of General Electric Company (NYSE: GE). GE Healthcare is a global provider of contrast media, medical technologies and services, and biomanufacturing solutions. GE Healthcare has acquired the exclusive rights from Rapidscan to produce and sell the pharmacological stress agent Rapiscan® (Regadenoson) in territories outside the USA, Canada and Mexico.
Our role in the transaction
Oaklins Cavendish, based in the UK, advised Radpidscan on its acquisition by GE Healthcare. Oaklins Cavendish has considerable experience in advising pharmaceutical and healthcare businesses. The team's specialist commented: “We are delighted to have advised the shareholders of Rapidscan and to have found in GE Healthcare the right buyer to continue to expand Rapidscan’s growing network of markets outside of North America. This acquisition will see Rapidscan and GE Healthcare unlock significant synergies from their complementary geographical reach and will meet the growing demand for Rapidscan’s specialist product.”
Talk to the deal team
Lord Leigh of Hurley
Oaklins Cavendish
Related deals
Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.
Learn moreitemedical has been acquired by Halma
itemedical, a Netherlands-based provider of digital platforms that integrate real-time patient data and alarms from a wide range of medical devices to support clinical decision-making and workflow efficiency in hospitals, has been acquired by Halma plc, a global group of life-saving technology companies. The acquisition represents a milestone in itemedical’s development and provides a platform for its next phase of growth. By joining Halma’s healthcare sector as a business unit of Halma subsidiary Static Systems Group (SSG), itemedical will strengthen its position as a provider of digital hospital workflow solutions, benefiting from access to a global network of technology businesses, resources to accelerate innovation and opportunities to expand its international footprint.
Learn moreIndigo Capital has acquired a minority stake in Vivason
Indigo Capital has acquired a minority stake in Vivason, a leading network of hearing care centers, to support the company’s growth and enable management to increase its ownership stake.
Learn more